- Report
- June 2026
- 295 Pages
Global
From €4625EUR$4,950USD£3,864GBP
- Report
- October 2026
- 288 Pages
Global
From €3901EUR$4,175USD£3,259GBP
- Report
- September 2026
- 310 Pages
Global
From €3901EUR$4,175USD£3,259GBP
- Report
- June 2026
- 290 Pages
Global
From €3878EUR$4,150USD£3,239GBP
- Report
- February 2026
- 250 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- April 2026
- 200 Pages
Global
From €2794EUR$2,990USD£2,334GBP
- Report
- July 2026
- 120 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- June 2026
- 120 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- April 2026
- 120 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- January 2026
- 150 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- September 2026
- 150 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- August 2026
- 120 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- May 2026
- 150 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- June 2026
- 200 Pages
Global
From €2794EUR$2,990USD£2,334GBP
- Report
- September 2026
- 216 Pages
Global
From €4579EUR$4,900USD£3,825GBP
- Report
- December 2025
- 196 Pages
Global
From €4579EUR$4,900USD£3,825GBP
- Report
- September 2026
- 184 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 186 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 190 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 184 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more